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In Brief
Molecular modeling of polyketide
synthase domains can yield insights into
the structure and function of these giant
and complex enzymes. Based on
modeling, mutations are devised that
shift the substrate scope of an
acyltransferase domain of a polyketide
synthase toward the incorporation of
artificial building blocks into the
biosynthesis of the important antibiotic
erythromycin to generate new
derivatives.0
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Polyketides are natural products frequently used for
the treatment of various diseases, but their structural
complexity hinders efficient derivatization. In this
context, we recently introduced enzyme-directed
mutasynthesis to incorporate non-native extender
units into the biosynthesis of erythromycin. Modeling
and mutagenesis studies led to the discovery of a
variant of an acyltransferase domain in the erythro-
mycin polyketide synthase capable of accepting a
propargylated substrate. Here, we extend molecular
rationalization of enzyme-substrate interactions
through modeling, to investigate the incorporation
of substrates with different degrees of saturation of
the malonic acid side chain. This allowed the engi-
neered biosynthesis of new erythromycin derivatives
and the introduction of additional mutations into the
AT domain for a further shift of the enzyme’s sub-
strate scope. Our approach yields non-native poly-
ketide structures with functional groups that will
simplify future derivatization approaches, and
provides a blueprint for the engineering of AT do-
mains to achieve efficient polyketide synthase diver-
sification.
INTRODUCTION
Polyketides (PKs) are a widespread class of natural products
with large pharmaceutical potential (Weissman and Leadlay,
2005). They frequently require structural alterations to become
relevant for pharmaceutical applications, highlighting the need
for efficient strategies toward their derivatization (Newman and
Cragg, 2012). This derivatization is complicated by the structural
complexity of PKs that contain a multitude of functional groups
and stereogenic centers (Hertweck, 2009).
In bacteria, giant cis-acyltransferase type I polyketide syn-
thases (PKSs) catalyze the key steps in the biosynthesis ofChemistry & Biology 22, 1425–143reduced PKs. In these modular enzymes, ketosynthase, acyl-
transferase (AT), and acyl carrier protein domains bring about
decarboxylative Claisen condensations between an enzyme-
bound acyl thioester and themalonic acid-based building blocks
used as extender units. In further reductive steps, optional ketor-
eductase, dehydratase, and enoylreductase domains catalyze
the stepwise reduction of the initial b-ketothioester product to
a secondary alcohol, olefin, or saturated fatty acid equivalent.
The general organization of the biosynthetic machinery is largely
conserved among all reduced PKs of bacterial origin, despite a
staggering structural variety (Hertweck, 2009).
Aside from alterations in redox pattern and stereochemical
configuration of PKs, the use of different biosynthetic building
blocks is an important source of diversity in this compound class
(Hertweck, 2009; Kushnir et al., 2012; Kwan et al., 2008; Lau
et al., 1999; Mo et al., 2010; Oliynyk et al., 1996; Quade et al.,
2012). In particular, derivatives of malonic acid-based extender
units can be incorporated in different modules of a PKS, adding
a potentially high degree of structural flexibility. In nature only a
relatively small number of extender units are utilized, in most
cases malonyl-coenzyme A (MCoA) and methylmalonyl-CoA
(MMCoA). Some AT domains can strictly discriminate between
MMCoA and MCoA as substrates, and we recently suggested
that the differentiation mechanism between the native substrate
MMCoA and the smaller alternative is subtle (Sundermann et al.,
2013). The exclusion of completely non-natural substrates does
not necessarily have to be strict, as evolutionary pressure on
this trait is absent. In experiments with the isolated module
6 of 6-deoxyerythronolide B synthase (DEBS), Koryakina et al.
(2013) showed a considerable level of acceptance of differently
substituted MCoA derivatives. In special cases, analogous
setups also work in vivo (Bravo-Rodriguez et al., 2014; Koryakina
et al., 2012).
In our experiments on the biosynthesis of erythromycin in its
native producerSaccharopolyspora erythraea, no tested artificial
extender unit was incorporated into the PK. Apparently, the
elevated substrate concentrations required to enforce their
acceptance by the PKS cannot be reached in vivo. This result
calls for mutagenesis to change the substrate profile of an AT.
Intrinsically, such an approach could facilitate targeted and
site-specific incorporations with the mutations focused on one0, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1425
Table 1. Substrates Investigated in This Study
R1 Compound Name
CH3 MMSNAC
CH2CHCH2 allyl-MSNAC (1)
CH2CCH propargyl-MSNAC (2)
CH2CH3 Et-MSNAC (3)
CH(CH3)2 iProp-MSNAC (4)
(CH2)3CH3 Bu-MSNAC (5)
(CH2)5CH3 Hex-MSNAC (6)
C6H5 Ph-MSNAC (7)
Figure 1. Snapshots ofMolecular Dynamics Simulations of theWild-
Type AT6 Domain and of AT6 Carrying the V295A Mutation with
Native and Non-native Substrates
(A) Alanine allows for greater flexibility of the binding pocket since this residue
adopts positions not accessible to valine (WT-AT6, rose; V295A AT6, ochre).
(B) Allyl-MSNAC (1) is placed inside the active site of V295A AT6 with the side
group of the malonyl moiety accommodated below Ala295 instead of side
by side.
(C) The triple bond of propargyl-MSNAC (2) does not readily fit in the active site
of WT-AT6. Notice the positioning of Arg222 outside the active site; Met235
and Val295 do not flank the substituent in the malonyl region.
(D) Improved positioning of 2 in the active site of the V295A variant.
(E) V295A AT6 with iProp-MSNAC (4) and (F) with Hex-MSNAC (6).
The substrate is colored according to the atom type,WT-AT6 is colored in rose
and V295A AT6 in ochre.module, while retaining the specificity of neighboring AT
domains.
In our work, we focused on the AT domain in module 6 of
DEBS. We employed enzyme-directed mutasynthesis as an
approach whereby an AT domain of a PKS is mutated to shift
its native substrate profile to a synthetic analog (Sundermann
et al., 2013). In contrast to previous approaches, enzyme-
directed mutasynthesis is not restricted to starter units of PK
biosynthetic pathways and, more importantly, does not rely on
the intrinsic substrate promiscuity of a PKS but enforces it
through targeted mutagenesis. We found that upon directed
mutagenesis of the active site in DEBS AT6, thioester-activated
2-propargylmalonate could serve as an extender unit, leading to
2-propargylerythromycin A. Here, we build on these findings to
examine whether active site mutations with different steric de-
mands in comparison with V295 implicated in the earlier work
would lower the substrate specificity of the enzyme on a broader
basis. We use molecular modeling and feeding experiments with
different malonic acid-based building blocks to investigate the
enzyme-substrate interactionsmore precisely. We then translate
the improved understanding into mutagenesis experiments to
further alter the substrate profile of the enzyme and synthesize
new erythromycin derivatives.
RESULTS AND DISCUSSION
For a systematic substrate screening, we synthesized
several substituted malonic acid thioesters (compounds 1–7
[Table 1]).
Substrate-Free Wild-Type and V295A AT6
Molecular dynamics (MD) simulations of substrate-free wild-type
(WT) and V295A AT6 reveal that the V295A mutation results
in a wider active site (Figure 1), mainly due to the increased
flexibility of the loop containing residue 295. The higher flexi-
bility caused by this mutation also reaches the b-sheet region
near Ala295 and the a-helix formed by residues 273–286 (Fig-
ure 1). Lastly, the Ala295 side chain can rotate 180 from the
Val295 orientation, thereby pointing to the outside of the active
site.1426 Chemistry & Biology 22, 1425–1430, November 19, 2015 ª2015Wild-Type AT6 with Native and Non-native Substrates
To further investigate the origins of substrate specificity, we per-
formed MD simulations of WT-AT6 with the native and two non-
native substrates, MMCoA, methylmalonyl-SNAC (MMSNAC),
and propargylmalonyl-SNAC (propargyl-MSNAC, 2), respec-
tively. First, we identified key molecular interactions between
WT-AT6 and MMCoA. Our model shows that the carboxylate
group of the malonate interacts with Arg222, Tyr297, and
Ser299. Gln198 has contacts to the thioester carbonyl group.
The side chain on theCa atomof the substrate is placed betweenElsevier Ltd All rights reserved
Met235 and Val295. These two amino acids control both
the stereochemistry and the size of the malonic acid side chain.
Ser197 is activated by His300 for a nucleophilic attack on the
thioester. Therefore, the thioester should come into close contact
with Ser197.
MMSNAC features themethylmalonyl moiety, but the thioester
region is shorter than in the natural substrateMMCoA. According
to previous experiments, WT-AT6 should be able to accept
MMSNAC (Klopries et al., 2013). Analysis of the molecular inter-
actions between WT-AT6 and MMSNAC shows little difference
compared with WT-AT6-MMCoA in the active site. Since
MMSNAC does not feature the CoA fragment, it shows fewer in-
teractions with the solvent-exposed part of the cavity hosting the
active site of WT-AT6. This results in a greater mobility of
the MMSNAC substrate inside the active site, as evidenced by
the lower root-mean-square deviation (RMSD) values of MMCoA
with respect to MMSNAC.
The simulations of WT-AT6 in complex with 2 show that the
binding is accompanied by major active site rearrangements
(Figure 1C and Table S1A). Arg222 is oriented outside of the
active site to accommodate 2, leaving only one NH2 group of
the Arg222 guanidinium moiety to interact with the malonate
(Figure 1C). In addition, interactions of Gln198 and Ser299 with
the substrate are weakened (Figure 1C and Table S1A) and the
triple bond of 2 adopts an unfavorable orientation with respect
to Met235 and Val295 (Figure 1C). Our findings are in agreement
with a recent report on the incorporation of propargyl-MCoA by
DEBS AT6 (Koryakina et al., 2013). In that study, CoA-activated
propargylmalonate was used in high concentrations, which
cannot be reached in vivo.
Our models of the enzyme-substrate complex show that the
correct positioning of the substrate and the conservation of
key interactions with the active site are the main factors govern-
ing substrate specificity in DEBS AT6. In the presence of high
concentrations of non-optimal substrates, purified PKS frag-
ments might accommodate the suitable substrate rotamer to
yield the artificial product, as reported by Koryakina et al. (2013).
V295A AT6 with Native and Non-native Substrates
WeperformedMDsimulationswith the native substrate bound to
V295A AT6 to rationalize its binding mode. The simulations with
MMCoA and MMSNAC show that this variant establishes a very
similar substrate-active site interaction network as the WT pro-
tein (Table S1B). This is in agreement with our previous experi-
mental findings with this enzyme variant, giving rise to a mixture
of erythromycin A and 2-propargylerythromycin A from a fermen-
tation supplemented with the artificial building block (Sunder-
mann et al., 2013). The single mutation thus would not switch,
but rather relax, the enzyme’s substrate specificity.
TheMD simulations of V295A AT6withMMCoA andMMSNAC
feature two differences compared with theWT simulations. First,
the position of the O atom of MMCoA and MMSNAC shifts with
respect to Arg222 (Table S1A). Second, residues Gln113,
Gln169, and Gln198 tend to move away from the substrates in
all V295A AT6 simulations (Figure 1 and Table S1). Gln113 and
Gln169 are not directly involved in interactions with the thioester
group of the substrate. Their role in the active site is possibly to
contribute to creating a polar environment at the bottom of the
active site to aid substrate insertion. Although Gln198 directly in-Chemistry & Biology 22, 1425–143teracts with the thioester moiety in the WT-AT6-MMCoA model,
previous studies of AT6-Q198A, -Q198P, and -Q198G showed
that this is not critical for activity (Sundermann et al., 2013).
V295A AT6 accommodates 2 in the active site (Figure 1A). The
simulation of V295A AT6 in complex with 2 indicates its correct
positioning (Figure 1D, compare Figure S2D for atoms naming,
Table S1B for distances). We found that the increase in loop flex-
ibility in V295A AT6 is important for the accommodation of 2,
and that Ala295 can adopt conformations not accessible to
Val295 (Figure 1A).
The simulations of V295A AT6 with bound ethylmalonyl-
SNAC (3), isopropylmalonyl-SNAC (4), and hexylmalonyl-
SNAC (6) showed that, with a larger substrate side chain, the
interactions with the active site become less structured (Figures
1E and 1F). While theMD simulations with 3 display a very similar
interaction pattern as the simulations with MMCoA, the models
of V295A AT6 bound to 4 show that the bulky isopropyl group
cannot be accommodated (Figure 1E). The interaction with
Tyr297 is lost and the isopropyl group is not placed between
Met235 and Ala295. The carboxylate group of 4 adopts a vertical
orientation with respect to the guanidinium moiety of Arg222
(Figure 1E), and the large lateral chain of 6 causes the active
site to repel it (Figure 1F and Table S1B).
Furthermore, the incorporation of 1 and phenylmalonyl-
SNAC (7) was investigated. For 1, larger distances between
Ser197Ca (Ser197OG) and the C atom of the substrate were
found: 6.32 ± 0.67 A˚ (4.25 ± 0.57 A˚) (Table S1). However, the
Ser197Ca-C distance tends to decrease toward the end of the
simulation (values close to 5.0 A˚), indicating that Ser197 gets
near the substrate. We found that the active site of WT-AT6 ac-
commodates 1 without disrupting any main interactions (Fig-
ure 1B and Table S1B).
In the case of 7, the planar aromatic ring is accommodated
with all the key distances in a range of values that makes sub-
strate binding possible, identifying it as a potential substrate
(see Table S1B for comparison with MMCoA, MMSNAC, and
Et-MSNAC).
Feeding Experiments
Besides the modeled V295A AT6, we tested variants V295L and
V295G in feeding experiments using S. erythraea NRRL-
B-24071. As previously shown, V295A AT6 is capable of pro-
ducing 2-propargylerythromycin A on an analytical scale,
when supplied with 2 in the fermentation medium. Under the
same conditions, V295L AT6 only produces erythromycin A,
whereas V295G AT6 displays a complete loss of activity (Sun-
dermann et al., 2013). To test whether any of these variants
were capable of incorporating non-natural extender units other
than 2, we performed feeding experiments with all derivatives
shown in Table 1. Each experiment was carried out with at least
four independent clones. Cultures of all variants were supplied
with the extender unit analogs in concentrations between
10 and 50 mM. Fermentation extracts were analyzed by liquid
chromatography-electrospray ionization mass spectrometry
(LC-ESI-MS).
Variant V295G did not give rise to erythromycin A or any deriv-
ative at a significant level, indicating that the variant is rendered
inactive by the mutation. In comparison with the WT, variant
V295L gave rise to lowered amounts of erythromycin A but did0, November 19, 2015 ª2015 Elsevier Ltd All rights reserved 1427
Figure 2. Results of Feeding Experiments
with S. erythraea DEBS V295A AT6
(A and B) General scheme for the experimental
outline. The malonic acid derivatives 1–3 were
supplied to S. erythraea to give rise to the corre-
sponding erythromycin derivatives (see table in B).
(C) LC-ESI-MS total ion chromatogram of a
fermentation extract from a culture supplied with 1.
It shows the corresponding 2-allylerythromycin A
(1e) next to the WT product erythromycin A (9).not show significant incorporation levels of any extender unit
analog. The WT control experiments also did not give rise to
any derivative. Feeding of 7 resulted in diminished cell growth
and abolished erythromycin production. Therefore, theoretical
prediction of its compatibility with variant V295A could not be
experimentally validated.
Upon supplying V295A AT6 with compounds 1–7, analogs 1–
3 were incorporated into the erythromycin assembly line, 2
serving as positive control. Incorporation was verified by
high-resolution MS and tandem MS experiments (Figure 2).
V295A AT6 thereby shows significant substrate promiscuity.
Variants supplied with 50 mM of any of the substrates
showed no production of either erythromycin A or any of the
natural product derivatives, and bacterial growth was dimin-
ished. Production levels were significantly lowered at 30 and
40 mM of all tested analogs. Incorporation efficiency was
similar for concentrations of 10 and 20 mM of each building
block in the medium. The concentration effect was unexpected,
as MMSNAC did not show toxicity or any other negative effect
in the tested concentration range (Klopries et al., 2013). How-
ever, malonic acid thioesters are potent electrophiles, which
were recently shown to be able to malonylate electrophilic
amino acids in proteins with possible negative effects on the
cell’s metabolism (Bao et al., 2013).
The concentration effect was reproducible over different
batches of the synthetic compounds and over independent
clones. Controls with SNAC and the corresponding free malonic
acid derivatives revealed a diminished production of erythro-
mycin caused by the free propargylmalonic acid and a sharp
decrease of production at a concentration of R30 mM SNAC.
Overall, this result indicates limited opportunities to increase
the yield of the fermentation of PK derivatives based solely on
precursor-directed biosynthesis.
Simple means such as altered concentrations of the supplied
extender unit analogs do not suffice to induce higher yields of
the targeted derivatives. Instead, the apparent KM value of
the analog has to be lowered to allow for incorporation at the
intracellular concentrations of the building block. The substrate
specificity of AT domains must hence be shifted by decreasing
acceptance of the native extender unit to lower by-product1428 Chemistry & Biology 22, 1425–1430, November 19, 2015 ª2015 Elsevier Ltd All rights rformation. Based on inspection of the
modeled structure of V295A AT6 with
bound 2, we decided to further reduce
steric hindrance in the active site through
additional mutations. The characteristic
YASH motif (Sundermann et al., 2013)
was altered to GAGH by site-directedmutagenesis, resulting in a triple variant (V295A, Y297G,
S299G). The resulting variant was found to be productive and
to yield a significantly higher level of 2-propargylerythromycin
(2e) relative to the V295A variant (Figure 3).
Comparison of Modeling and Feeding Experiments
The results of the feeding experiments are in agreement with
the computational predictions. According to the modeling re-
sults, V295A AT6 should be able to accept propargyl, ethyl,
allyl, and phenyl side chains. Feeding experiments revealed
the synthesis of 2-ethyl- and 2-allylerythromycin A, confirming
the acceptance of 3 and 1 as substrates. In agreement
with the computational predictions, no isopropyl and hexyl de-
rivatives were detected. The modeled structure of V295A AT6
with bound propargyl-MSNAC suggested that further reduction
of steric hindrance in the active site will allow more efficient
substrate incorporation. This was experimentally found for a tri-
ple variant.
Conclusion
Here, we show that a single mutation causes significant relax-
ation of the substrate specificity of DEBS AT6. We found that
the main requirements on the substrate are the size of the side
chain and its flexibility. Hex-MSNAC and iProp-MSNAC are
not accepted, whereas propargyl-, Et-, and allyl-MSNAC are.
The comparably low incorporation rate is due to the fact that
these artificial substrates compete for acceptance with natural
MMCoA. In addition, stiff moieties such as the propargyl
group should adopt a proper orientation within the AT6 active
site. Small flexible building blocks such as Et-MSNAC are
accepted similarly to the natural substrate. Theoretical find-
ings show that the incorporation of non-native substrates
is favored under the following conditions: (1) close proximity
between the thioester group of the substrate and Ser197, (2)
substrate side-chain placement between Met235 and Val295,
and (3) interaction of Arg222 with the malonate carboxylate
group.
With this work, we prove that PKS specificity can be altered by
site-directed mutagenesis, and demonstrate how few rationally
selected mutations can lead to the incorporation of non-nativeeserved
Figure 3. Comparison of V295A AT6 with the
New Triple Variant
WT DEBS does not incorporate the synthetic
building block 2 in detectable quantities, and
V295A AT6 yields low amounts. The triple variant
shows a 3.79-fold increase in productivity. For this
figure, the abundance of all signals was normalized
to 9, which was set to 1; the chromatogram is
shown from 6.55 to 6.95 min. Productivity was
quantified based on LC-ESI-MS signals. a, V295A-
9; b, triple variant 9; c, V295A 2e; d, triple variant 2e.building blocks. This shows that design principles established in
the engineering of small enzymes can be transferred to giant
PKS (Kazlauskas, 2005; Morley and Kazlauskas, 2005; Reetz,
2013), but require a thorough enzymological investigation ahead
of reaching significant preparative value. In addition, we are able
to propose factors regulating AT6 activity. Thus, we provide the
first rationalization of substrate incorporation by a PKS, based
not only on feeding experiments but also on molecular modeling
of enzyme-substrate interactions.
SIGNIFICANCE
Type I PKSs are a large group of biosynthetic enzymes with
high importance for the production of medicinal natural
products. However, PKS manipulation toward the biosyn-
thesis of polyketide derivatives poses long-standing
challenges forwhich the knowledgeof their substrate recog-
nition mechanism is a key aspect. Of particular relevance is
the selective introduction of artificial building blocks into
the biosynthetic pathway. Thus, we addressed the question
of how acyltransferase domains within bacterial type I PKS
recruit incoming extender units. Biomolecular modeling
was used to predict the substrate flexibility of an acyltrans-
ferase domain and to analyze the molecular interactions in
the active site. The substrate profile was experimentally
investigated using differently substituted derivatives of ma-
lonyl-SNAC. Based on these results, amodified acyltransfer-
ase domain with significantly altered substrate specificity
was designed. At present, the engineering of polyketide
biosynthesis is limited by the lack of rationalization of the
propertiesofmutatedPKS.Our studies indicate that an inter-
disciplinary approach can efficiently tackle this problem.
EXPERIMENTAL PROCEDURES
MD simulations of WT-AT6 and V295A AT6 with several non-native substrates
(Table 1)wereperformedusing our previously reportedmodel of AT6 as template
(Sundermann et al., 2013).
After building the models, CHARMM31b1 (Brooks et al., 1983) was em-
ployed for energy minimizations. VMD1.9 (Humphrey et al., 1996) was em-
ployed to neutralize the system and to solvate it in a box of water with 12 A˚Chemistry & Biology 22, 1425–1430, November 19, 2015distance between the protein and the walls of the
solvent box, as well as for visualization and anal-
ysis. Short MD simulations were performed for
equilibration before running unconstrained pro-
duction MD for 30 or 50 ns (NPT ensemble).
All MD simulations were performed using
NAMD2.9 (Phillips et al., 2005). The temperaturewas set to 300 K and a time step of 2 fs was used. The parameters of the sub-
strates were generated using SwissParam (Zoete et al., 2011). The
CHARMM22 force field was employed (Mackerell et al., 2004). RMSD values
were calculated for the backbone atoms of residues 21–440 of the protein
and for all atoms of the substrate.
Plasmids encoding for mutated DEBS3-AT6 were introduced via conjuga-
tive plasmid transfer from Escherichia coli ET12567/pUZ8002 into
S. erythraea DAT6hygR. Resulting clones were cultivated in SM3 medium.
S. erythraea NRRL-B-24071 and S. erythraea DAT6hygR carrying a non-
mutated DEBS3 expression served as controls. Cultures were supplied with
malonic acid derivatives (10–50 mM) and analyzed by LC-ESI-MS and ESI-
MS2 of ethyl acetate extracts (see Supplemental Information).
Synthetic procedures and protocols for the mutagenesis of DEBS AT6
together with analytical data can be found in Klopries et al. (2015).
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